Head-to-head
Ivim Health vs bmiMD
Compared on both medications across the eight dimensions this database records. They differ on 7 of those eight. bmiMD is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
Ivim Health is $353 a month all-in for tirzepatide; bmiMD is $179. Over twelve months that is $4,236 against $1,668. Value Scores are 46.3 and 91.6 out of 100.
Tirzepatide
Plan pages: Ivim Health plans · bmiMD plans
At 10 mg/week, Ivim Health is $353 a month all-in and bmiMD is $179 — $174 apart, or $2,088 across a year. Over twelve months the totals are $4,236 (billed monthly) and $1,668 (prepaid term).
Ivim Health prices tirzepatide by dose: $208 per month at 2.5 mg rising to $278 at 10 mg, a difference of $70 a month between the bottom and top of the ladder. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.
bmiMD charges a flat $179 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
| Dose | Ivim Health | Rank | bmiMD | Rank | Cheaper |
|---|---|---|---|---|---|
| 2.5 mg | $208 | 10/31 | $179 | 5/31 | bmiMD by $29 |
| 5 mg | — | — | $179 | 3/17 | only bmiMD publishes |
| 7.5 mg | — | — | $179 | 3/17 | only bmiMD publishes |
| 10 mg | $278 | 7/27 | $179 | 3/27 | bmiMD by $99 |
| 12.5 mg | — | — | $179 | 3/17 | only bmiMD publishes |
| 15 mg | — | — | $179 | 3/17 | only bmiMD publishes |
bmiMD is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 27 programs this database can rank on tirzepatide, Ivim Health sits 16 of 27 on all-in monthly cost and bmiMD sits 2. There are 13 other programs priced between them. The field median is $339 and the floor is $169, so bmiMD is below the median and the other is above it. Ivim Health is $184 above the cheapest tirzepatide program on record. bmiMD is $10 above the cheapest tirzepatide program on record.
LillyDirect (Zepbound), the lowest FDA-approved tirzepatide channel here, is $449 a month — Ivim Health undercuts it by $96, bmiMD by $270. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | Ivim Health | bmiMD | Cheaper |
|---|---|---|---|
| Month to month | $278 | $179 | bmiMD by $99 |
| 3-month term | — | $159 | only bmiMD publishes this term |
| 6-month term | — | $149 | only bmiMD publishes this term |
| 12-month term | — | $139 | only bmiMD publishes this term |
| Settled dose | Ivim Health | bmiMD | Difference |
|---|---|---|---|
| 2.5 mg | $3,396 | $2,148 | $1,248 apart |
| 5 mg | — | $2,148 | one side unpriced |
| 7.5 mg | — | $2,148 | one side unpriced |
| 10 mg | $4,236 | $2,148 | $2,088 apart |
| 12.5 mg | — | $2,148 | one side unpriced |
| 15 mg | — | $2,148 | one side unpriced |
Ivim Health publishes no rate for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $4,166 on Ivim Health and $2,148 on bmiMD — $2,018 apart, and a different gap from the $2,088 you would get by multiplying the monthly difference by twelve. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
That calculation is partial: Ivim Health publishes no price at 2 of the 6 doses, so the maintenance rate stands in for the missing steps rather than a number the company has stated.
Value Scores are 46.3 for Ivim Health and 91.6 for bmiMD, against a tirzepatide category floor of $169. bmiMD leads by 45.3 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| Ivim Health | 33.5 | 12.8 | 0 | 0 | 46.3 |
| bmiMD | 66.1 | 10.5 | 10 | 5 | 91.6 |
Semaglutide
Plan pages: Ivim Health plans · bmiMD plans
At 2.4 mg/week, Ivim Health is $224 a month all-in and bmiMD is $129 — $95 apart, or $1,140 across a year. Over twelve months the totals are $2,688 (billed monthly) and $1,188 (prepaid term).
Ivim Health charges a flat $149 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated.
bmiMD charges a flat $129 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
bmiMD is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Value Scores are 53.1 for Ivim Health and 95.5 for bmiMD, against a semaglutide category floor of $129. bmiMD leads by 42.4 points, driven mostly by price.
Where the two programs differ
All-in monthly
bmiMD is cheaper month to month — $179 against $353, a gap of $174 every month, or $2,088 across a year if both rates hold.
Cancellation terms
Cancellation differs: Ivim Health states Cancel anytime, while bmiMD states Per provider terms; confirm cancellation policy at enrollment. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
Ivim Health asks for Month-to-month; bmiMD asks for Monthly, 3-month, 6-month, or 12-month plans; price varies by term, not by dose. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Dose policy
bmiMD charges one price at every dose; Ivim Health prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.
Evidence status
The two prices are not equally well evidenced. Ivim Health's figure is provider-stated and bmiMD's is reported. Ivim Health rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.
Membership fee
Ivim Health charges a membership of $75 a month on top of the medication. That is already folded into the all-in figures above — it is broken out here because a membership is a recurring charge that continues even in a month you skip a shipment.
Twelve-month cost
Over twelve months the totals are $4,236 for Ivim Health and $1,668 for bmiMD. bmiMD is lower by $2,568 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
Ivim Health Official site
Ivim combines a $75/month membership with tiered medication pricing; its all-in semaglutide figure ($149) is competitive, while tirzepatide lands mid-pack at $278 all-in at the 10 mg basis.
It does not publicly name its compounding pharmacy; the record shows Partner pharmacies, so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel anytime; availability is stated as ~50 states.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — ivimhealth.com pricing captures 2026-08-05
Watch: Dose-tiered tirzepatide means the advertised start price understates maintenance cost; compare on the maintenance column.
bmiMD Official site
bmiMD is a compounded GLP-1 telehealth platform notable for flat per-dose pricing — the rate stays the same whether you're at 2.5 mg or 15 mg — and one of the widest plan-tier menus in the market. Its $99/mo semaglutide and $139/mo tirzepatide on the twelve-month plan are the lowest annualized figures in the dataset for both molecules.
It does not publicly name its compounding pharmacy; the record shows Named 503A pharmacy partner (specific pharmacy not publicly identified on pricing page), so who actually makes the medication cannot be independently verified; commitment terms are Monthly, 3-month, 6-month, or 12-month plans; price varies by term, not by dose; cancellation is Per provider terms; confirm cancellation policy at enrollment; availability is stated as Availability at enrollment; confirm your state at intake.
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com cheapest-compounded-tirzepatide-online, capture verified 2026-07-14
Watch: bmiMD's 12-month semaglutide plan at $99/mo is the lowest annualized sema figure in our dataset, beating NexLife's $119/mo and Oak's $133 m2m. Month-to-month sema at $129 also beats Oak's $133, making bmiMD the new m2m sema leader. Tirzepatide 12-month at $139 ties NexLife. Figures are reported status from RangeYourself's July 2026 first-party captures; our independent checkout is pending.
What neither record tells you
Ivim Health does not publish
- no tirzepatide price at 5, 7.5, 12.5, 15 mg per week
- no published twelve-month tirzepatide rate
- no semaglutide price at 0.5, 1, 1.7 mg per week
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says ~50 states
bmiMD does not publish
- no named compounding pharmacy
- no state-by-state availability list — it says Availability at enrollment; confirm your state at intake
- no specific cancellation or refund terms
Ask Ivim Health and bmiMD for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Evidence may be upgraded. bmiMD carries a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Prepaid terms move the annual figures. bmiMD publishes a twelve-month rate of $139 a month against $179 month-to-month. Read those next to the cancellation terms, not the monthly rate.
Which one suits which reader
On the lowest standing monthly rate for tirzepatide, bmiMD Official site wins this matchup. If you expect to titrate to the top of the ladder, bmimd's flat pricing is worth more than the headline gap suggests; if you want to be able to pause without still paying, bmimd carries no membership; and if you would rather trust a better-evidenced number, ivim health's price rests on stronger provenance.
Both figures should be checked at the provider's own checkout before you pay. Ivim Health's tirzepatide price is provider-stated as of 2026-08-05; bmiMD's is reported as of 2026-07-14.
Questions
Is Ivim Health or bmiMD cheaper for tirzepatide?
bmiMD is cheaper on all-in monthly cost at 10 mg/week: $179 against $353, a difference of $174 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of Ivim Health versus bmiMD?
Ivim Health works out to $4,236 across twelve months and bmiMD to $1,668, on the plan terms each publishes.
Does Ivim Health or bmiMD raise the price as the dose goes up?
Ivim Health: yes, it prices by dose. bmiMD: no, it charges one flat rate at every dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do Ivim Health and bmiMD differ?
7 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of Ivim Health and bmiMD names its pharmacy?
Neither. Ivim Health records Partner pharmacies and bmiMD records Named 503A pharmacy partner (specific pharmacy not publicly identified on pricing page). Without a named pharmacy, neither program's licensing or inspection history can be checked before you order.
How well evidenced are the Ivim Health and bmiMD prices?
Ivim Health's tirzepatide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-08-05. bmiMD's is reported, captured 2026-07-14. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Which is cheaper for semaglutide?
bmiMD, at $129 a month all-in against $224 at 2.4 mg/week. The two programs do not necessarily lead on both medications.
Official sources: Ivim Health official site · bmiMD official site. Compounded tirzepatide and semaglutide are not FDA-approved products.